Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.
Daniel C Betticher, Geoffrey Delmore, Urs Breitenstein...
https://pubmed.ncbi.nlm.nih.gov/23636645/Actively Recruiting
Led by Montefiore Medical Center · Updated on 2026-10-16
41
Participants Needed
1
Research Sites
19 weeks
Total Duration
Researchers are evaluating hairstyling methods to improve the effectiveness of scalp cooling in preventing chemotherapy-induced hair loss among patients with skin of color, specifically those with curly or kinky hair types receiving chemotherapy for breast or non-small cell lung cancer. The study aims to understand how these hair preparation techniques affect scalp cooling success and to explore the molecular mechanisms and biomarkers linked to hair loss prevention. Participants will be assigned to one of three groups scalp cooling with braided hairstyles like cornrows or twists, scalp cooling after coating hair with a conditioner and water mix, or no scalp cooling. These hairstyling methods are intended to reduce hair bulkiness and improve scalp contact with the cooling cap. The study also includes follow-up to assess persistent hair loss after chemotherapy completion. Participants will be monitored throughout chemotherapy and up to six months afterward. Researchers will measure hair density and adverse effects related to hair loss at several time points. They will also collect hair samples for molecular analysis to identify gene expression changes and predictive biomarkers. Patient distress related to hair loss will be assessed at multiple intervals to understand the emotional impact of hair preservation methods.
CONDITIONS
Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
B
Beth McLellan, MD
Y
Yana Kost, BA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Montefiore Medical Center
Lead Sponsor
Paxman Coolers Limited
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Scalp cooling (hairstyle) | Scalp cooling (conditioner/emulsion) | No scalp cooling (control) |
|---|---|---|---|
| What it is | Device‑based scalp cooling using the patient’s preferred hairstyle (braids, cornrows, or twists) to fit the cooling cap | Device‑based scalp cooling after coating hair with a conditioner and water emulsion to aid cooling cap fit | No scalp cooling is applied |
| Role in trial | Experimental device method being evaluated | Experimental device method being evaluated | Control condition reflecting usual care supportive management |
| Primary use | To reduce chemotherapy‑induced hair loss during taxane‑based treatment | To reduce chemotherapy‑induced hair loss during taxane‑based treatment | Usual supportive care without preventive cooling |
| Administration method | Cooling cap applied after styling hair into braids, cornrows, or twists to fit device | Cooling cap applied after hair is coated with conditioner and water emulsion to facilitate cooling cap fit | No cooling device applied |
| Evidence status | Scalp cooling is supported by meta‑analyses showing a large reduction in hair loss risk during chemotherapy | Scalp cooling is supported by meta‑analyses showing a large reduction in hair loss risk during chemotherapy | No proactive intervention; hair loss risk remains unmitigated |
| Important risks | Reported side effects include mild discomfort such as headaches, cold sensation, chills | Reported side effects include mild discomfort such as headaches, cold sensation, chills | No device‑related risks |
| Important limitations | Efficacy may vary by chemotherapy regimen and hair type; standardized cooling durations are not yet defined | Efficacy may vary by chemotherapy regimen and hair type; standardized cooling durations are not yet defined | No mitigation of alopecia, which may increase psychosocial burden |
| Patient impact | Hair preservation may reduce distress and improve quality of life during chemotherapy | Hair preservation may reduce distress and improve quality of life during chemotherapy | Higher rates of hair loss may increase distress |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Duration of chemotherapy treatment (at least 4 cycles)
Participants receive scalp cooling using one of two hairstyling techniques or no scalp cooling during taxane-based chemotherapy.
Visits during chemotherapy sessions
Duration - Up to 6 months after chemotherapy completion
Participants are monitored for up to 6 months after chemotherapy to assess hair loss severity and patient distress.
Periodic follow-up visits
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Daniel C Betticher, Geoffrey Delmore, Urs Breitenstein...
https://pubmed.ncbi.nlm.nih.gov/23636645/Christa Slaught, Michael Roman, Sharona Yashar...
https://pubmed.ncbi.nlm.nih.gov/33956617/Asma Dilawari, Christopher Gallagher, Princess Alintah...
https://pubmed.ncbi.nlm.nih.gov/33512741/F E M Janssen, G M J Van Leeuwen, A A Van Steenhoven
https://pubmed.ncbi.nlm.nih.gov/16177530/Giselle de Barros Silva, Kathryn Ciccolini, Aline Donati...
https://pubmed.ncbi.nlm.nih.gov/32622629/Tiffany T Mayo, Valerie D Callender
https://pubmed.ncbi.nlm.nih.gov/33937486/Manon M C Komen, Carolien H Smorenburg, Corina J G van den Hurk...
https://pubmed.ncbi.nlm.nih.gov/23650021/Kay Friedrichs, Martin H Carstensen
https://pubmed.ncbi.nlm.nih.gov/25279292/Brooke A Rice, Elizabeth S Ver Hoeve, Amy N DeLuca...
https://pubmed.ncbi.nlm.nih.gov/28921303/Ralph M Trüeb
https://pubmed.ncbi.nlm.nih.gov/21045702/Montefiore Medical Center
Lead Sponsor
Paxman Coolers Limited
Collaborating Sponsor